tiprankstipranks
Citius Pharmaceuticals (CTXR)
NASDAQ:CTXR
US Market

Citius Pharmaceuticals (CTXR) Technical Analysis

Compare
1,680 Followers

Technical Sentiment

Overall Consensus
Sell
5Bullish
6Neutral
11Bearish
Technical Analysis Consensus
Sell
1Bullish
6Neutral
3Bearish
Moving Average Consensus
Sell
4Bullish
0Neutral
8Bearish
Citius Pharmaceuticals’s (CTXR) Moving Averages Convergence Divergence (MACD) indicator is -0.20, suggesting Citius Pharmaceuticals is a Sell.
Citius Pharmaceuticals’s (CTXR) 20-Day exponential moving average is 1.62, while Citius Pharmaceuticals’s (CTXR) share price is $1.55, making it a Sell.
Citius Pharmaceuticals’s (CTXR) 50-Day exponential moving average is 2.29, while Citius Pharmaceuticals’s (CTXR) share price is $1.55, making it a Sell.

Citius Pharmaceuticals (CTXR) Pivot Points

Mar 31, 2025, 01:05 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.05
1.13
1.22
1.30
1.38
1.46
1.55
Fibonacci
1.13
1.19
1.23
1.30
1.36
1.40
1.46
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Citius Pharmaceuticals (CTXR) Moving Averages

Mar 31, 2025, 01:05 AM
Period
Simple
Exponential
MA5
1.45Buy
1.46Buy
MA10
1.51Buy
1.50Buy
MA20
1.57Sell
1.62Sell
MA50
2.16Sell
2.29Sell
MA100
3.47Sell
4.15Sell
MA200
9.27Sell
8.92Sell
Citius Pharmaceuticals’s (CTXR) 10-Day exponential moving average is 1.50, while Citius Pharmaceuticals’s (CTXR) share price is $1.55, making it a Buy.
Citius Pharmaceuticals’s (CTXR) 100-Day exponential moving average is 4.15, while Citius Pharmaceuticals’s (CTXR) share price is $1.55, making it a Sell.
Citius Pharmaceuticals’s (CTXR) stock price is $1.55 and Citius Pharmaceuticals’s (CTXR) 50-day simple moving average is 2.16, creating a Sell signal.
Citius Pharmaceuticals’s (CTXR) stock price is $1.55 and Citius Pharmaceuticals’s (CTXR) 100-day simple moving average is 3.47, creating a Sell signal.
Citius Pharmaceuticals’s (CTXR) stock price is $1.55 and Citius Pharmaceuticals’s (CTXR) 200-day simple moving average is 9.27, creating a Sell signal.

Citius Pharmaceuticals (CTXR) Technical Indicators

Mar 31, 2025, 01:05 AM
Name
Value
Implied Action
RSI (14)
41.52
Neutral
STOCH (9,6)
29.06
Neutral
STOCHRSI (14)
27.21
Neutral
MACD (12,26)
-0.20
Sell
ADX (14)
23.07
Neutral
Williams %R
-33.53
Buy
CCI (14)
-58.42
Neutral
ATR (14)
0.20
-
Ultimate Oscillator
41.50
Neutral
ROC
-1.90
Sell
Citius Pharmaceuticals’s (CTXR) Relative Strength Index (RSI) is 41.52, creating a Neutral signal.
Citius Pharmaceuticals’s (CTXR) Trend Strength Indicator (ADX) is 23.07, creating a Neutral signal.
Citius Pharmaceuticals’s (CTXR) Commodity Channel Index (CCI) is -58.42, creating a Neutral signal.
Citius Pharmaceuticals’s (CTXR) Price Rate of Change (ROC) is -1.90, creating a Sell signal.

FAQ

Is CTXR a Buy, Hold, or Sell?
Based on CTXR’s technical indicators, CTXR is a Sell.
    What is CTXR’s RSI (14)?
    CTXR’s RSI (14) is 41.52, which suggests CTXR is a Neutral.
      What is CTXR’s MACD?
      CTXR’s MACD is -0.20, which suggests CTXR is a Sell.
        What is CTXR’s 5-day moving average?
        CTXR’s 5-day moving average is 1.45, which suggests CTXR is a Buy.
          What is CTXR’s 20-day moving average?
          CTXR 20-day moving average is 1.57, which suggests CTXR is a Sell.
            What is CTXR’s 50-day moving average?
            CTXR’s 50-day moving average is 2.16, which suggests CTXR is a Sell.
              What is CTXR’s 200-day moving average?
              CTXR’s 200-day moving average is 9.27, which suggests CTXR is a Sell.
                What is CTXR’s Williams % R (14)?
                CTXR’s Williams % R (14) is -33.53, which suggests CTXR is a Buy.
                  What is CTXR’s CCI (14)?
                  CTXR’s CCI (14) is -58.42, which suggests CTXR is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis